Blood Glucose Self-Monitoring
                             
                            
                            
                                
                            
                            
                                
                            
                            
                            
                                
                                    
                                            
	"Blood Glucose Self-Monitoring" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
	
	
		
			
			
				Self evaluation of whole blood glucose levels outside the clinical laboratory. A digital or battery-operated reflectance meter may be used. It has wide application in controlling unstable insulin-dependent diabetes.
    
			
			
				
				
					
						| Descriptor ID | D015190 | 
					
						| MeSH Number(s) | E01.370.225.124.100.105 E01.370.374.100 E01.370.520.100 E02.900.100 E05.200.124.100.105 | 
					
						| Concept/Terms | Blood Glucose Self-MonitoringBlood Glucose Self-MonitoringBlood Glucose Self MonitoringGlucose, Blood, Self-MonitoringSelf-Monitoring, Blood GlucoseBlood Glucose Self-MonitoringsGlucose Self-Monitoring, BloodGlucose Self-Monitorings, BloodSelf Monitoring, Blood GlucoseSelf-Monitorings, Blood GlucoseMonitoring, Home Blood GlucoseBlood Sugar Self-MonitoringBlood Sugar Self MonitoringBlood Sugar Self-MonitoringsSelf-Monitoring, Blood SugarSelf-Monitorings, Blood SugarSugar Self-Monitoring, BloodSugar Self-Monitorings, BloodHome Blood Glucose MonitoringGlucose, Blood, Self Monitoring
 | 
					
				
			 
			
				Below are MeSH descriptors whose meaning is more general than "Blood Glucose Self-Monitoring".
				
			 
			
			
				Below are MeSH descriptors whose meaning is more specific than "Blood Glucose Self-Monitoring".
				
			 
		 
	 
 
                                        
                                            
	
	
		
			
			
					
				This graph shows the total number of publications written about "Blood Glucose Self-Monitoring" by people in this website by year, and whether "Blood Glucose Self-Monitoring" was a major or minor topic of these publications. 
				
					 
                    To see the data from this visualization as text, 
click here. 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
| 2004 | 0 | 1 | 1 | 
| 2016 | 1 | 0 | 1 | 
| 2017 | 0 | 1 | 1 | 
| 2018 | 1 | 1 | 2 | 
| 2019 | 1 | 0 | 1 | 
| 2020 | 0 | 2 | 2 | 
| 2021 | 0 | 1 | 1 | 
| 2022 | 0 | 1 | 1 | 
| 2023 | 1 | 2 | 3 | 
| 2025 | 1 | 0 | 1 | 
                    To return to the timeline, 
click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "Blood Glucose Self-Monitoring" by people in Profiles.
						
					
								- 
								Considerations With Using a CGM in Older Individuals. Sr Care Pharm. 2025 Jul 01; 40(7):283-287. 
- 
								Does use of continuous or flash glucose monitors decrease hypoglycemia episodes in T2D? J Fam Pract. 2023 07; 72(6):271-275. 
- 
								Real-Time Continuous Glucose Monitoring Reduced Costly Diabetes-Related Events in Adolescents and Young Adults despite Lack of Short-Term Reduction in Hemoglobin A1c. Pediatr Diabetes. 2023; 2023:5253515. 
- 
								Observational assessments of the relationship of dietary and pharmacological treatment on continuous measures of dysglycemia over 24 hours in women with gestational diabetes. Front Endocrinol (Lausanne). 2023; 14:1065985. 
- 
								Glucose variability is associated with an adverse vascular profile but only in the presence of insulin resistance in individuals with type 1 diabetes: An observational study. Diab Vasc Dis Res. 2022 May-Jun; 19(3):14791641221103217. 
- 
								Study protocol: Minimum effective low dose: anti-human thymocyte globulin (MELD-ATG): phase II, dose ranging, efficacy study of antithymocyte globulin (ATG) within 6 weeks of diagnosis of type 1 diabetes. BMJ Open. 2021 12 07; 11(12):e053669. 
- 
								Effect of CFTR modulator therapy on cystic fibrosis-related diabetes. J Diabetes Complications. 2021 06; 35(6):107845. 
- 
								Accumulating Physical Activity in Short or Brief Bouts for Glycemic Control in Adults With Prediabetes and Diabetes. Can J Diabetes. 2020 Dec; 44(8):759-767. 
- 
								Insulin Dosing, Glycemic Control, and Perinatal Outcomes in Pregnancies Complicated by Type-2 Diabetes. Am J Perinatol. 2021 05; 38(6):535-543. 
- 
								Continuous Glucose Monitoring Profiles in Healthy Nondiabetic Participants: A Multicenter Prospective Study. J Clin Endocrinol Metab. 2019 10 01; 104(10):4356-4364.